StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Guided Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -303.8%. For fiscal 2025 it was -309.3%, against -30114.3% the year before. The highest annual figure on record is -48.2% in fiscal 2010.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-309.3%+29805.0
FY2024Dec 31, 2024-30114.3%−26586.7
FY2023Dec 31, 2023-3527.6%+22110.9
FY2022Dec 31, 2022-25638.5%−22722.4
FY2021Dec 31, 2021-2916.0%−1884.7
FY2020Dec 31, 2020-1031.4%+1571.4
FY2019Dec 31, 2019-2602.8%+113.0
FY2018Dec 31, 2018-2715.8%−1436.7
FY2017Dec 31, 2017-1279.1%+13547.1
FY2015Dec 31, 2015-14826.2%−1489.3
FY2014Dec 31, 2014-13336.9%−12531.3
FY2013Dec 31, 2013-805.6%−677.4
FY2012Dec 31, 2012-128.3%+59.6
FY2011Dec 31, 2011-187.8%−139.6
FY2010Dec 31, 2010-48.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-120.3%+5863.0
Q3 FY2025Sep 30, 2025-808.3%+707.3
Q2 FY2025Jun 30, 2025-652.1%+2768.3
Q4 FY2024Dec 31, 2024-53400.0%−49568.2
Q1 FY2024Mar 31, 2024-5983.3%+34816.7
Q4 FY2023Dec 31, 2023-1515.6%+12824.4
Q2 FY2023Jun 30, 2023-3420.5%+5439.5
Q1 FY2023Mar 31, 2023-3831.8%−3106.8
Q3 FY2022Sep 30, 2022-40800.0%−38236.8
Q2 FY2022Jun 30, 2022-14340.0%+13710.0
Q1 FY2022Mar 31, 2022-8860.0%−7708.0
Q4 FY2021Dec 31, 2021-725.0%−526.3
Q3 FY2021Sep 30, 2021-2563.2%−1531.9
Q2 FY2021Jun 30, 2021-28050.0%−9250.0
Q4 FY2020Dec 31, 2020-1152.0%+31548.0
Q3 FY2020Sep 30, 2020-198.7%+1229.1
Q4 FY2019Dec 31, 2019-1031.3%+37.8
Q3 FY2019Sep 30, 2019-18800.0%−7100.0
Q2 FY2019Jun 30, 2019-32700.0%−26562.5
Q1 FY2019Mar 31, 2019-1427.8%+7972.2
Q4 FY2018Dec 31, 2018-1069.0%−385.9
Q3 FY2018Sep 30, 2018-11700.0%−7642.4
Q2 FY2018Jun 30, 2018-6137.5%−5524.9
Q1 FY2018Mar 31, 2018-9400.0%−6952.4
Q4 FY2017Dec 31, 2017-683.2%+31.6
Q3 FY2017Sep 30, 2017-4057.6%–
Q2 FY2017Jun 30, 2017-612.6%–
Q1 FY2017Mar 31, 2017-2447.6%–
Q3 FY2016Sep 30, 2016-714.7%–

More Guided Therapeutics figures

See a number that looks wrong?